Dot, a digital odour intelligence company, has secured £4.2 million in new funding to accelerate its global expansion and develop next-generation scent-analysis technologies capable of detecting biological change long before traditional systems notice anything is wrong.
The funding round was oversubscribed, signalling strong investor confidence in Dot’s unusual but highly promising approach to monitoring health, agriculture and environmental systems.
Key investors include Blackfinch Ventures, Pihl Family Office, long-standing supporter Luke Ding, and a new strategic investor.
Turning Scent into Data
For over a decade, Dot’s scientists have been studying the subtle chemical signals emitted by living systems. Humans, animals, plants and ecosystems all release volatile organic compounds (VOCs), microscopic airborne signatures revealing presence, health status and emerging biological risks.
Dot’s proprietary platform, dot.core™, captures these scent signatures, converting them into structured data. The result is a form of predictive biological intelligence capable of identifying problems earlier than conventional monitoring methods.
What began as academic research has now evolved into a scalable infrastructure designed to detect and interpret biological change across multiple sectors.
Four Sectors, One Platform
Dot’s technology operates across four interconnected areas:
Animal health
Plant health
Environmental monitoring
By translating scent into actionable data, organisations can move from reactive response to proactive protection, spotting pest outbreaks, disease risks or environmental changes before they escalate.
The company blends expertise from chemical ecology, insect behaviour, public health and data science, alongside laboratory testing and field research, to create early-warning solutions that are both targeted and sustainable.
Investment Fuels Global Expansion
The fresh funding will support Dot’s next stage of growth as it moves from scientific breakthrough to global deployment.
Key priorities include:
Expanding international partnerships for products such as BugScents™
Scaling scientific services across industries
Accelerating development of AI-powered odour intelligence technologies
Increasing manufacturing capacity
Strengthening validation and regulatory evidence
Professor James Logan, founder and CEO of Dot, described the investment as a strong endorsement of the company’s direction.
He told That's Busin ess: “This funding reflects confidence in our team, our platform and our ability to translate world-class science into real-world solutions. It allows us to accelerate growth, deepen partnerships and deliver earlier, smarter detection where it matters most.”
A New Frontier in Detection
Investors believe digital odour technology could transform how biological threats are identified and managed.
Backed by a growing patent portfolio and a strong scientific team, Dot aims to position scent-based intelligence as a global infrastructure for early detection across health, agriculture and environmental protection.
In a world increasingly focused on prevention rather than reaction, Dot is betting that the smallest airborne signals could provide the earliest warnings of the biggest problems.
No comments:
Post a Comment